We are an integral and active member of the global health community. We share our knowledge and expertise to ensure policy-makers, researchers and industry have the data they need to make informed decisions on investment in global health R&D.

The annual launch of the G-FINDER report

Since its inception, the launch of the G-FINDER neglected disease report has provided an annual opportunity for key players in the global health community to come together. A panel made up of prominent members of the global health community discusses key issues in global health and provides an opportunity for the attendees to contribute to the discussion.

The most recent G-FINDER neglected disease report was launched in January 2022. The session included a presentation of the report’s findings and insights as well as a high-level discussion on the future of neglected diesease research and opportunities and threats created by the COVID-19 pandemic. Speakers included:

  • Janet Ginnard, Director of Strategy, Unitaid
  • Dr. Kavita Singh, Director South East Asia, Drugs for Neglected Disease initiative (DNDi)
  • Dr. Melinda Moree, Senior Program Officer, Bill and Melinda Gates Foundation

The report is available here, along with the accompanying press release

The launch event for the 2021 G-FINDER neglected disease report can be viewed here

Connecting with the global health community

Members of our team regularly attend and present at local and international meetings of the global health community. As part of our participation in these events, we meet with key partners from around the world to foster collaboration and information exchange.

Here are some of the ways we’ve engaged in 2020 to date:

Utilising evidence and analysis, we engage in activities drawing attention to diverse global health issues

In addition to our regular attendance at the bi-annual Global Health Alliance Australia meetings in Melbourne, members of our team attended a number of events in 2019, including:

  • World Health Summit, Berlin
  • DNDand founders’ symposium, Berlin
  • World Conference on Access to Medical Products – Achieving the SDGs 2030, New Delhi
  • Foundation for the National Institutes of Health’s Gene Drive Research Forum meeting, Addis Ababa
  • Global Health Security Conference, Sydney
  • Impact Investing: Bond Recipient Insights Roundtable, Sydney

The events we attended in 2018 included:

  • Malaria World Congress, Melbourne
  • Health in the 2030 Agenda for Sustainable Development symposium, Basel
  • World Conference on Access to Medical Products – Achieving the SDGs 2030, New Delhi

Our CEO Dr Nick Chapman was the only non-UN organisation’s representative to be invited to present at the 2016 Open-Ended Meeting of WHO Member States on the report of the Consultative Expert Working Group on R&D.

Collaborations with global health organisations

Having conducted the G-FINDER project annually for over a decade, Policy Cures Research is recognised as a critical partner to organisations with an interest in measuring funding for global health, leading to regular opportunities to collaborate with and contribute to publications from other global health organisations.

Policy Cures Research is a member of the Global Health Technologies Coalition Global Partners Network, informing and participating in the coalition’s multilateral advocacy activities. We are actively involved in writing the “Investments in malaria R&D” chapter of the annual World Malaria Report and share our data and findings with the Global Institute’s Knowledge Portal on innovation and access to medicines, Seek Development’s Donor Tracker, and the WHO’s Global Observatory on Health R&D.

Academic engagement

Policy Cures Research’s CEO Dr Nick Chapman is a guest lecturer at the University of Sydney, and members of our team frequently provide lectures to students enrolled in the Master of International Public Health and Master of Global Health programmes at the University of Sydney.

Advice to stakeholders

We work with partners to expand the reach of our evidence and analysis. We regularly provide global health stakeholders, including the Bill & Melinda Gates Foundation and PATH, with additional tailored analysis of our in response to requests for additional detail or context. We also advise organisations on how to collect, store and manage data.